eDeviation is a Switzerland-based startup founded in 2013. The company specializes in providing clinical and endpoint adjudication, protocol deviations, data and safety monitoring boards, and data monitoring committees management through cost-effective and compliant software solutions. With over 16 years of experience, eDeviation aims to simplify the complex and expensive nature of clinical research while maintaining high quality. The company is driven by expertise, innovation, flexibility, scalability, and customer service, and has contributed to over 300 clinical trials on more than 10,000 investigator sites.
As the clinical research industry becomes increasingly intricate, eDeviation seeks to support clinical teams by streamlining their daily operations without compromising on standards. The company's parent organization, Ethical GmbH, was founded by the Italian Company GM Servizi. Ethical's staff manages the Endpoint Adjudication and Clinical Trial Committees group on LinkedIn.
Although specific industry details and recent investments are not provided, eDeviation's focus on delivering cost-effective and compliant solutions in the clinical research space positions it as an important player in the industry. With its strong track record and expertise, eDeviation has the potential to attract significant investor interest and further establish itself as a trusted resource for clinical research support.
There is no investment information
No recent news or press coverage available for Ethical GmbH.